|
Dr. Andrew Lyon
Within the CSCC he served on council, as Division Head of Educational Affairs, as the CSCC website editor, on publications committee, and on several local organizing committees for annual meetings. He served terms on the CACB board and on numerous exam committees and was active on the executives of the Alberta Society of Clinical Chemists and Saskatchewan Society of Clinical Chemists and supported the IFCC as website editor. Andrew won the CACB award for outstanding contribution to the profession of clinical biochemistry in 2005. Andrew is currently Division Head of Clinical Biochemistry of the Saskatoon Health Region and a clinical associate professor of Pathology and Laboratory Medicine at the University of Saskatchewan and teaching general pathology residents. He has published 65 papers and recently edited a journal supplement on preterm birth. |
|
Dr. Stephen Hill
Stephen has served as treasurer, vice-president and president of the OSCC, board member and chair of the CACB, and is currently the secretary of the CSCC. He has been a member, vice-chair and chair of the QMPLS chemistry committee. Research interests include Evidence-Based Laboratory Medicine and Cardiac Biomarkers. He is also active in education. He coordinates a 3rd year undergraduate biochemistry course, is active in the undergraduate medicine program, and is the program director for the clinical biochemistry post-doctoral training program at McMaster. A long suffering Hamilton Ti-Cats fan, he also take solace in the fact that while Hamilton does not have an NHL team, …… neither does Toronto. |
|
Dr. Jennifer Shea
Jennifer is currently the Division Head of Clinical Chemistry at the Saint John Regional Hospital in Saint John, New Brunswick and an assistant professor with the Department of Pathology at Dalhousie University. Her interests include quality assurance in the chemistry laboratory and postmortem toxicology. Aside from acting as secretary on the CSCC Council, Jennifer is also a member of the CACB Certification Committee. As well, she serves on the New Brunswick Society of Clinical Chemists as treasurer. |
|
Dr. Ivan Blasutig
Ivan is a councillor of the OSCC and is a member of the CACB credentials committee. His research is focused around the discovery and validation of novel biomarkers for pancreatic cancer and the molecular mechanisms behind cancer progression. His clinical interests lie in immunodiagnostics and autoimmune testing. |
|
Dr. Allison Venner
She is member of several professional groups, including the Alberta Association of Clinical Doctoral Scientists, Alberta Society of Clinical Chemists, Alberta Society for Human Toxicology, Central Zone Medical Staff Association, American Association of Clinical Chemistry, Society for Young Clinical Laboratorians and Canadian Obesity Network. She is currently the Secretary for the Alberta Society of Clinical Chemists. |
|
Dr. Julie Shaw
Following completion of her Masters degree, Julie moved to the University of Toronto where she completed her PhD in the Department of Laboratory Medicine and Pathobiology under the supervision of Dr. Eleftherios Diamandis. Julie’s doctoral work looked at the role of kallikrein serine proteases in the female reproductive system. From this work, Julie developed an interest in Reproductive Biology and moved to the University of Edinburgh, following her PhD, to complete a postdoctoral fellowship in the Centre for Reproductive Biology at the University of Edinburgh in Scotland. Julie returned to Canada in 2010 to begin her post-doctoral training in Clinical Chemistry at the University of Toronto. She completed her training fellowship in 2012 and moved to The Ottawa Hospital. Currently, Julie is working as a Clinical Biochemist and the Co-Medical/Scientific Director for POCT in the Division of Biochemistry at The Ottawa Hospital. She is also an Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa. Julie has a research interest in Laboratory Test Standardization and was recently awarded a grant from Grand Challenges of Canada to fund standardization of creatinine measurements in Guyana, South America. The aim of this project is to standardize creatinine measurements to allow for reporting of eGFR in Guyana for earlier detection of chronic kidney disease. Outside of work, Julie enjoys curling, golfing and most of all World travel. |
|
Dr. Isolde Seiden-Long Dr. Seiden Long completed her B.Sc. at the University of Waterloo (1999, Honours Biology Co-op). She later went on to pursue her Ph.D. at the University of Toronto (2005, Department of Medical Biophysics), supported by NSERC and CIHR research awards. She completed postdoctoral studies in the Clinical Chemistry Diploma program at the University of Toronto (2007, Department of Laboratory Medicine and Pathobiology). Dr. Seiden Long is currently a Fellow of the Canadian Academy of Clinical Biochemistry, as well as a Diplomat of the American Board of Clinical Chemistry. Dr. Seiden Long is a Clinical Biochemist with Calgary Laboratory Services, Program Director for the Clinical Biochemistry Fellowship program and Clinical Assistant Professor, Department of Pathology and Laboratory Medicine at the University of Calgary. The Calgary program is the first new Fellowship program in Canada in more than 30 years and opened their doors to their first trainee in July 2013. She has been active with the CSCC, serving as associate editor of the CSCC news for 4 years and photography coordinator and abstract reviewer for several CSCC meetings. |
|
Dr. Anna Fuezery
Anna has been working as a clinical biochemist with Alberta Health Services for three years. She is located in Edmonton where she consults for two major community hospitals and four suburban stat laboratories. She has recently accepted co-directorship of Edmonton’s city-wide point-of-care testing (POCT) program and is also the medical co-chair of the Alberta POCT Network. When she is not busy with clinical duties, Anna spends her time teaching and mentoring others. She is an Assistant Clinical Professor at the University of Alberta and regularly lectures in the Department of Laboratory Medicine’s undergraduate medical laboratory science program. She is also actively involved in the department’s Postdoctoral Clinical Biochemistry Fellowship Program not only as a co-director but as a mentor for preanalytics, high volume general chemistry, and POCT. |
|
Dr. Danijela Konforte
As the clinical biochemist at LifeLabs, Dr. Konforte supports routine chemistry and urinalysis testing as well as special chemistry testing including clinical toxicology, trace metals and various HPLC- and mass spectrometry- based tests. Since 2014 she has worked as the laboratory director for the Sudbury and Thunder Bay LifeLabs locations. In July 2013 Dr. Konforte completed certification to become a Fellow of the Canadian Academy of Clinical Biochemistry and has served as a CSCC councilor and an associate editor for the CSCC Newsletter. Dr. Konforte is the author or co-author of 12 peer-reviewed papers, 11 posters and abstracts in her field of study, and her work has been well received at local, national and international conferences. |
|
Dr. Vathany Kulasingam
Dr. Kulasingam has an active research program focused on early diagnosis of ovarian cancer by utilizing emerging high-throughput technologies. She has already published over 25 papers related to mass spectrometry, proteomics and biomarker discovery. Her current interests include novel tumor biomarker discovery and application of proteomics to clinical practice. In addition to research, she lectures in a number of graduate level courses at the University of Toronto and is actively involved in teaching Postdoctoral Biochemistry trainees. She continues to participate in committees related to Clinical Chemistry such as being a Councillor for the Ontario Society of Clinical Chemists and the CSCC, a member for the Document Development Committee on Liquid Chromatography/Mass Spectrometry Methods for the Clinical and Laboratory Standards Institute (CLSI) and being an editorial board member for the Translational Proteomics journal. |
Andrew pursued biochemistry at Queen’s University in Kingston, Ontario obtaining a BSc in 1983 and PhD in 1988. He trained as a clinical chemist at the University of Ottawa, and then as a senior research fellow in drug monitoring at the University of Washington and subsequently held faculty positions at the University of Saskatchewan and the University of Calgary & Calgary Lab Services.
Stephen graduated with a BSc and PhD from the University of Western Ontario. He completed his post-doctoral training in Clinical Biochemistry from McMaster University in 1989 and obtained certification and fellowship from the CACB in 1990. Since 1990, he has been a clinical biochemist with the Hamilton Regional Laboratory Medicine Program, serving at the Hamilton General Hospital, St. Joseph’s Hospital and the McMaster University Medical Centre, and an Associate Professor in the Department of Pathology and Molecular Medicine at McMaster University.
Jennifer Shea completed her undergraduate degree at Mount Allison University in Sackville, NB (Honors Biology, Minor Chemistry) followed by a PhD in Human Genetics at Memorial University of Newfoundland where the focus of her research was the genetic and biochemical etiology of obesity. She then completed post-doctoral training in Clinical Chemistry at the University of Toronto in 2013 and obtained certification and fellowship with the CACB in 2014.
Ivan graduated with a BSc and PhD from the Department of Molecular Genetics at the University of Toronto. He completed his post-doctoral training in Clinical Biochemistry from the University of Toronto in 2010 and obtained certification and fellowship from the CACB in 2011. He is a clinical biochemist at the University Health Network, an organization comprised of Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre and Toronto Rehab. He is also an Assistant Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto where he is active in both teaching and research.
After obtaining her B.Sc. degree (2005; Biological Sciences and Nutrition) from the University of Alberta and her interdisciplinary Ph.D. degree (2009; Faculty of Kinesiology and Dept. of Medical Science) from the University of Calgary, Dr. Venner completed her Postdoctoral Fellowship Diploma in Clinical Chemistry at the University of Toronto in 2011. She was certified as a clinical biochemist and joined the CACB in 2013. She has been working as a clinical biochemist with Alberta Health Services (AHS) for 2 years. With AHS, Dr. Venner is based at the Red Deer Regional Hospital and is the clinical biochemist for the rural hospitals in the Central Zone. In addition, she is actively involved in a number of AHS provincial Laboratory Networks, including the Chemistry Network, POCT Network, Interzone Network and Toxicology Network. She has also been appointed as Clinical Lecturer at the University of Alberta, where she teaches undergraduate lectures. She enjoys the opportunity to provide guidance and education to the clinical laboratory staff and visiting students/residents. She has multiple publications in a variety of areas ranging from childhood obesity and renal cell carcinoma to reference intervals. Within the CSCC, she has served as Councillor (2012-2013). She is currently the Head of the Education and Scientific Affairs Division. She has received the CSCC Best Oral Presentation Award (2011), as well as the CSCC Trainee Travel Award (2011) and the OSCC Travel Award (2010).
Julie was raised in Caledon Ontario. She moved to Kingston to complete her Undergraduate degree in Life Sciences at Queen’s University. Julie also completed a Masters degree in the Department of Pathology and Molecular Medicine at Queen’s University, under the supervision of Dr. Lois Mulligan.
Dr. Anna Füzéry completed her B.Sc. degree at the University of Toronto (2001; Chemistry), and her Ph.D. degree at the University of Wisconsin (2009, Biochemistry). She completed her postdoctoral training in clinical biochemistry at the Johns Hopkins University (2013). Anna is currently a Fellow of the Canadian Academy of Clinical Biochemistry, a Fellow of the National Academy of Clinical Biochemistry, and a Diplomat of the American Board of Clinical Chemistry.
Dr. Konforte is a clinical biochemist at LifeLabs community laboratory in Toronto. Prior to joining LifeLabs in 2012 she completed clinical chemistry fellowship at the University of Toronto. Danijela holds a doctorate in immunology from the University of Toronto. Following graduation, she dedicated time to the postdoctoral research of novel drugs for acute myeloid leukemia at the Ontario Cancer Institute. 
Dr. Vathany Kulasingam completed her PhD at the Department of Laboratory Medicine and Pathobiology, University of Toronto. Following her PhD, she completed the post-doctoral training diploma program in Clinical Chemistry at the University of Toronto in 2010. Dr. Kulasingam is currently a clinical biochemist at the University Health Network in Toronto, an Assistant Professor at the Faculty of Medicine, University of Toronto and a Fellow of the Canadian Academy of Clinical Biochemistry.